Login to Your Account

Novartis Offers $4.5B To Buy Biotech Giant Chiron

By Karen Pihl-Carey

Friday, September 2, 2005
Less than a day after Chiron Corp. announced its Liverpool manufacturing facility could again produce flu vaccine, Novartis AG offered $4.5 billion to acquire the company. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription